NCT05890976: An ongoing trial by Novo Nordisk A/S
This trial is ongoing. It must report results 1 month, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05890976 |
|---|---|
| Title | Efficacy and Safety of Oral Semaglutide 50 mg Once Daily in Chinese Adults With Overweight or Obesity (OASIS 3) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 30, 2023 |
| Completion date | Jan. 16, 2025 |
| Required reporting date | Jan. 16, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Nov. 25, 2025 |
| Days late | None |